AADAC anticorps

N° du produit ABIN7235694

Détail du produit anti-AADAC anticorps

Antigène: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AADAC est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of human AADAC

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:100

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur AADAC

Antigène: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Autre désignation: AADAC (AADAC Produits)

Synonymes: anticorps MGC89272, anticorps AADAC, anticorps CES5A1, anticorps DAC, anticorps Aada, anticorps 5033417E09Rik, anticorps AI265437, anticorps arylacetamide deacetylase, anticorps arylacetamide deacetylase S homeolog, anticorps Arylacetamide deacetylase, anticorps arylacetamide deacetylase (esterase), anticorps LOC100056411, anticorps aadac, anticorps AADAC, anticorps aadac.S, anticorps LOC100451808, anticorps ACD3, anticorps PTRG_10278, anticorps aaad, anticorps Aadac

Sujet: Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.

Poids moléculaire: 46 kDa

UniProt: P22760